Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas: A distinct clinicopathological entity with an aggressive clinical behavior

American Journal of Pathology

Volumn 155, Issue 2, 1999, Pages 483-492

  Berti, Emilio ^a   Tomasini, Dario ^c   Vermeer, Maarten H ^b   Meijer, Chris J L M ^b   Alessi, Elvio ^a   Willemze, Rein ^b  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Institute of Dermatologic Sciences ^*

Author keywords

[No Author keywords available]

Indexed keywords

CD2 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD5 ANTIGEN; CD7 ANTIGEN; CD8 ANTIGEN; CYTOKINE; KI 67 ANTIGEN; T LYMPHOCYTE ANTIGEN;

ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CYTOTOXIC T LYMPHOCYTE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; MALE; MEMORY CELL; NATURAL KILLER CELL; PANNICULITIS; PRIORITY JOURNAL; SKIN LYMPHOMA; T CELL LYMPHOMA; T LYMPHOCYTE SUBPOPULATION;

EID: 0032787926     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65144-9     Document Type: Article

References (61)

1. Willemze R, Kerl H, Sterry W, Berti E, Cerroni L, Chimenti S, Diaz-Perez JL, Geerts ML, Goos M, Knobler R, Ralfkiaer E, Santucci M, Smith N, Wechsler J, van Vloten WA, Meijer CJ: EORTC classification for primary cutaneous lymphomas: a proposal from the cutaneous lymphoma study group of the european organization for research and treatment of cancer. Blood 1997, 90:354-371
2. Caputo R, Berti E, Monti M, Cavicchini S: A verrucoid epidermotropic OKT8-positive lymphoma. Am J Dermatopathol 1983, 5:159-164
3. Buechner SA, Winkelmann RK, Banks PM: T cells and T-cell subsets in mycosis fungoides and parapsoriasis. A study of 18 cases with anti-human T cell monoclonal antibodies and histochemical techniques. Arch Dermatol 1984, 120:897-905
4. Deneau DG, Wood GS, Beckstead J, Hoppe RT, Price N: Woringer-Kolopp disease (pagetoid reticulosis): four cases with histopathologic, ultrastructural, and immunohistologic observations. Arch Dermatol 1984, 120:1045-1051
5. Mackie RM, Turbitt ML: A case of pagetoid reticulosis bearing the cytotoxic suppressor surface marker on the lymphoid infiltrate: further evidence that pagetoid reticulosis is not a variant of mycosis fungoides. Br J Dermatol 1984, 110:89-94
6. Gonzalez M, Martin-Pascual M, San Miguel J, Caballero MD, Lopez Borrasca A: Phenotypic characterization of skin-infiltrating cells in pagetoid reticulosis by monoclonal antibodies. Acta Derm Venereol 1984, 64:421-424
7. Mielke V, Wolff HH, Winzer M, Sterry W: Localized and disseminated pagetoid reticulosis. Diagnostic immunophenotypical findings. Arch Dermatol 1989, 125:402-406
8. Smoller BR, Stewart M, Warnke R: A case of Woringer-Kolopp disease with Ki-1 (CD30)+ cytotoxic/suppressor cells. Arch Dermatol 1992, 128:526-529
9. Burns MK, Chan LS, Cooper KD: Woringer-Kolopp disease (localized pagetoid reticulosis) or unilesional mycosis fungoides? An analysis of height cases with benign disease. Arch Dermatol 1995, 131:325-329
10. Jensen JR, Thestrup-Pedersen K: Subpopulations of T lymphocytes in a patient with fulminant mycosis fungoides. Acta Derm Venereol 1980, 60:159-161
11. Bennett SR, Greer JP, Stein RS, Glick AD, Cousar JB, Collins RD: Death due to splenic rupture in suppressor cell mycosis fungoides: a case report. Am J Clin Pathol 1984, 82:104-109
12. Jimbow K, Maeda K, Ito Y, Ishida O, Takami T: Heterogeneity of cutaneous T-cell lymphoma: phenotypic and ultrastructural characterization of four unusual cases. Cancer 1985, 56:2458-2469
13. Ohkohchi K, Aiba S, Tagami H: OKT8-reactive cell mycosis fungoides. Arch Dermatol 1986, 122:20-22
14. Fujiwara Y, Abe Y, Kuyama M, Arata J, Yoshino T, Akagi T, Miyoshi K: CD8+ cutaneous T-cell lymphoma with pagetoid epidermotropism, and angiocentric, and angiodestructive infiltration. Arch Dermatol 1990, 126:801-804
15. Agnarsson BA, Vonderheid EC, Kadin EM: Cutaneous T cell lymphoma with suppressor/cytotoxic (CD8) phenotype: identification of rapidly progressive and chronic subtypes. J Am Acad Dermatol 1990, 22:569-577
16. Urrutia S, Piris MA, Orradre JL, Martinez B, Cruz MA, Garcia-Almagro D: Cytotoxic/suppressor (CD8+, CD4-) cutaneous T-cell Lymphoma with aggressive course. Am J Dermatopath 1990, 12: 603-606
17. Marti RM, Estrach T, Palou J, Urbano-Ispizua A, Gratacos J, Cervera R, Feliu E, Grau JM, Mascara JM: Specific cutaneous lesions in a CD8+ peripheral T-cell lymphoma. Int J Dermatol 1992, 31:624-628
18. Quarterman MJ, Lesher JL, Davis LS, Pantazis CG, Mullins S: Rapidly progressive CD8-positive cutaneous T-cell lymphoma with tongue involvement. Am J Dermatopathol 1995, 17:287-291
19. Zalman LS, Martin DE, Jung G, Muller-Eberhard HJ: The cytolytic protein of human lymphocytes related to the ninth component (C9) of human complement: isolation from anti-CD3-activated peripheral blood mononuclear cells. Proc Natl Acad Sci USA 1987, 84:2426-2429
20. Hudig D, Ewoldt GR, Woodard SL: Proteases and lymphocyte killing mechanisms. Curr Opin Immunol 1993, 5:90-96
21. Anderson P, Nagler-Anderson C, O'Brien C, Levine H, Watkins S, Slayter HS, Blue ML, Schlossman SF: A monoclonal antibody reactive with a 15-kd cytoplasmic granule-associated protein defines a subpopulation of CD8+ T lymphocytes. J Immunol 1990, 144:574-582
22. Medley QG, Kedersha N. O'Brien S, Tian Q, Schlossman SF, Streuli M, Anderson P: Characterization of GMP-17, a granule membrane protein that moves to the plasma membrane of natural killer cells following target cell recognition. Proc Natl Acad Sci USA 1996, 93: 685-689
23. Koizumi H, Liu CC, Zheng LM, Joag SV, Bayne NK, Holoshitz T, Young JD: Expression of perforin and serine esterases by human γ/δ T cells. J Exp Med 1991, 173:449-502
24. Liu CC, Rafii S, Granelli-Piperno A, Trapani JA, Young JD: Perforin and serine esterase gene expression in stimulated human T cells. Kinetics, mitogen requirements, and effects of cyclosporin A. J Exp Med 1989, 170:2105-2118
25. Smyth MJ, Ortaldo JR, Shinkai YI, Yagita H, Nakata M, Okumura K, Young HA: Interleukin 2 induction of pore-forming protein gene expression in human peripheral blood CD8+ T cells: J Exp Med 1990, 171:1269-1281
26. Kummer JA, Kamp AM, van Katwijk M, Brakenhoff JP, Radosevic K, van Leeuwen AM, Borst J, Verweij CL, Hack CE: Production and characterization of monoclonal antibodies raised against recombinant human granzyme A and B and showing cross reactions with the natural proteins. J Immunol Methods 1993, 163:77-83
27. Cordell JL, Falini B, Erber WN, Grosh AK, Abdulaziz Z, MacDonald S, Pulford KA, Stein H, Mason DY: Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984, 32:219-229
28. Cattoretti G, Pileri S, Parravicini C, Becker MH, Poggi S, Bifulco C, Key G, D'Amato L, Sabattini E, Feudale E, Reynolds F, Gerdes J, Rilke F: Antigen unmasking on formalin-fixed, paraffin-embedded tissue sections. J Pathol 1993, 171:83-98
29. Bottaro M, Berti E, Biondi A, Migone N, Crosti L: Heteroduplex analysis of T-cell receptor γ gene rearrangements for diagnosis and monitoring of cutaneous T-cell lymphomas. Blood 1994, 83:3271-3278
30. Lin JC, Lin SC, De BK, Chan WC, Evatt BL: Precision of genotyping of Epstein-Barr virus by polimerase chain reaction using three gene loci (EBNA-2, EBNA-3C and EBER): predominance of type A virus associated with Hodgkin's disease. Blood 1993, 81:3372-3381
31. Jiwa NM, Kanavaros P, van der Valk P, Walboomers JM, Hortsman A, Vos W, Mullink H, Meijer CJ: Expression of c-myc and bcl-2 oncogene products in Reed-Sternberg cells independent of presence of Epstein-Barr virus. J Clin Pathol 1993, 46:211-217
32. Isaacson PG: Gastrointestinal lymphoma. Hum Pathol 1994, 25: 1020-1029
33. Hamann D, Baars PA, Rep MH, Hooibrink B, Kerkhof-Garde SR, Klein MR, van Lier RA: Phenotypic and functional separation of memory and effector human CD8+ T cells. J Exp Med 1997, 186:1407-1418
34. Fuhlbrigge RC, Kieffer JD, Armerding D, Kupper TS: Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells. Nature 1997, 389:978-981
35. Ketron LW, Goodman MH: Multiple lesions of skin apparently of epithelial origin resembling clinically mycosis fungoides: report of a case. Arch Dermatol Syph 1931, 24:758-777
36. Jaffe ES, Chan JK, Su IJ, Frizzera G, Mori S, Feller AC, Ho FC: Report of the workshop on nasal and related extranodal angiocentric T/Natural killer cell lymphomas: definitions, differential diagnosis and epidemiology. Am J Surg Pathol 1996, 20:103-111
37. Nakamura S, Suchi T, Koshikawa T, Kitoh K, Koike T, Komatsu H, Iida S, Kagami Y, Ogura M, Katoh E, Kurita S, Suzuki I, Kobashi Y, Yamabe H, Hirabayashi N, Ueda R, Takahashi T: Clinicopathologic study of CD56 (NCAM)-positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tract. Am J Surg Pathol 1995, 19:284-296
38. Emile JF, Boulland ML, Haioun C, Kanavaros P, Petrella T, Delfau-Larue MH, Bensussan A, Farcet JP, Gaulard P: CD5-CD56+ T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas. Blood 1996, 87: 1466-1473
39. Macon WR, Williams ME, Greer JP, Hammer RD, Glick AD, Collins RD, Cousar JB: Natural killer-like T-cell lymphomas: aggressive lymphomas of T-large granular lymphocytes. Blood 1996, 87:1474-1483
40. Cooke CB, Krenacs L, Stetler-Stevenson M, Greiner TC, Raffeld M, Kingma DW, Abruzzo L, Frantz C, Kaviani M, Jaffe ES: Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic γ/δ T-cell origin. Blood 1996, 88:4265-4274
41. Berti E, Cerri A, Cavicchini S, Delia D, Soligo D, Alessi E, Caputo R: Primary cutaneous γ/δ T-cell lymphoma presenting as disseminated pagetoid reticulosis. J Invest Dermatol 1991, 96:718-722
42. Sterry W, Hauschild A: Loss of leucocyte common antigen (CD45) on atypical lymphocytes in the localized but not disseminated type of pagetoid reticulosis. Br J Dermatol 1991, 125:238-242
43. de Bruin PC, Kummer JA, van der Valk P, van Heerde P, Kluin PM, Willemze R, Ossenkoppele GJ, Radaszkiewicz T, Meijer CJ: Granzyme B-expressing peripheral T-cell lymphomas: neoplastic equivalents of activated cytotoxic T cells with preference for mucosa-associated lymphoid tissue localization. Blood 1994, 84:3785-3791
44. Foss HD, Anagnostopoulos I, Araujo I, Assaf C, Demel G, Kummer JA, Hummel M, Stein H: Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules. Blood 1996, 88:4005-4011
45. Matutes E, Coelho E, Aguado MJ, Morilla R, Crawford A, Owusu-Ankomah K, Catovsky D: Expression of TIA-1 and TIA-2 in T cell malignancies and T cell lymphocytosis. J Clin Pathol 1996, 49:154-158
46. Krenacs L, Wellmann A, Sorbara L, Himmelmann AW, Bagdi E, Jaffe ES, Raffeld M: Cytotoxic cell antigen expression in anaplastic large cell lymphomas of T-and null-cell type and Hodgkin's disease: evidence for distinct cellular origin. Blood 1997, 89:980-989
47. Daum S, Foss HD, Anagnostopoulos J, Dederke B, Demel G, Araujo I, Rieken EO, Stein H: Expression of cytotoxic molecules in intestinal T-cell lymphomas. The German study group on intestinal non-Hodgkin lymphoma. J Pathol 1997, 182:311-317
48. Kummer JA, Vermeer MH, Dukers D, Meijer CJ, Willemze R: Most primary cutaneous CD30-positive lymphoproliferative disorders have a CD4-positive cytotoxic T-cell phenotype. J Invest Dermatol 1997, 109:636-640
49. Chan JK, Sin VC, Ng CS, Lau WH: Cutaneous relapse of nasal T-cell lymphoma clinically mimicking erythema multiforme. Pathology 1989, 21:164-168
50. Chan JK, Tsang WY, Lau WH, Cheung MM, Ng WF, Yuen WC, Ng CS: Aggressive T/natural killer cell lymphoma presenting as testicular tumor. Cancer 1996, 77: 1198-1205
51. Takeshita M, Kimura N, Suzumiya J, Ohshima K, Kikuchi M, Watanabe R, Okamura T, Goto H: Angiocentric lymphoma with granulomatous panniculitis in the skin expressing natural killer cell and large granular T-cell phenotypes. Virchows Arch A 1994, 425:499-504
52. Kumar S, Krenacs L, Medeiros J, Elenitoba-Johnson KS, Greiner TC, Sorbara L, Kingma DW, Raffeid M, Jaffe ES: Subcutaneous panniculitic T-cell lymphoma is a tumor of cytotoxic T-lymphocytes. Hum Pathol 1998, 29:397-403
53. Salhany KE, Macon WR, Choi JK, Elenitsas R, Lessin SR, Felgar RE, Wilson DM, Przyblski GK, Lister J, Wasik MA, Swerdlow SH: Subcutaneous panniculitis-like T-cell lymphoma: clinicopathologic, immunophenotypic, and genotypic analysis of α/beta and γ/delta subtypes. Am J Surg Pathol 1998, 22:881-893
54. Harris NL, Jaffe ES, Stein H, Banks PM, Cleary ML, Delsol G, De Wolf-Peters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink HK, Pileri SA, Piris MA, Ralfkiaer E, Warnke RA: A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994, 84:1361-1392
55. Jaffe EF, Krenacs L, Raffeld M: Classification of T-cell and NK-cell neoplasms based on the REAL classification. Ann Oncol 1997, 8 Suppl 2:17-24
56. Burns MK, Cooper KD: Cutaneous T-cell lymphoma associated with HIV infection. J Am Acad Dermatol 1993, 29:394-399
57. Beljaards RC, Meijer CJ, Scheffer E, Toonstra J, van Vloten WA, van der Putte SC, Geerts ML, Willemze R: Prognostic significance of CD30 (Ki-1/Ber-H2) expression in primary cutaneous large-cell lymphomas of T-cell origin: a clinicopathologic and immunohistochemical study in 20 patients. Am J Pathol 1989, 135:1169-1178
58. Kikuchi A, Sakuraoka K, Kurihara S, Akiyama M, Shimizu H, Nishikawa T: CD8+ cutaneous anaplastic large-cell lymphoma: report of two cases with immunophenotying, T-cell-receptor gene rearrangement and electron microscopic studies. Br J Dermatol 1992, 126: 404-408
59. Vowels BR, Lessin SR, Cassin M, Jaworsky C, Benoit B, Wolfe JT, and Rook AH: Th2 cytokines mRNA expression in skin in cutaneous T-cell lymphoma. J Invest Dermatol 1994, 103:669-673
60. Dummer R, Heald PW, Nestle FO, Ludwig E, Laine E, Hemmi S, Burg G: Sézary syndrome T-cell clones display T-helper 2 cytokines and express the accessory factor-1 (interferon-γ receptor β chain). Blood 1996, 88:1383-1389
61. Asadullah K, Docke WD, Volk HD, Sterry W: Cytokines and cutaneous T-cell lymphomas. Exp Dermatol 1998, 7:314-320